Circadian time-dependent hepatic and renal toxicities to valproic acid in mice

References

• Altunbasak S, Yildizdas D, Anarat A, Burgut H. 2001. Renal tubular dysfunction in epileptic children on valproic acid therapy. Pediatr Nephrol. 16:256–259.10.1007/s004670000535
   PubMed Web of Science ®Google Scholar
• Amathieu R, Levesque E, Merle JC, Chemit M, Costentin C, Compagnon P, Dhonneur G. 2013. Insuffisances hépatiques aiguës sévères d’origine toxique: prise en charge étiologique et symptomatique [Severe toxic acute liver failure: etiology and treatment]. Annales Françaises d’Anesthésie et de Réanimation. 32:416–421.10.1016/j.annfar.2013.03.004
   PubMed Web of Science ®Google Scholar
• Au JS, Pockros PJ. 2013. Drug-induced liver injury from antiepileptic drugs. Clin Liver Dis. 17:687–697.10.1016/j.cld.2013.07.011
   PubMed Web of Science ®Google Scholar
• Balsalobre A, Damiola F, Schibler U. 1998. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 93:929–937.10.1016/S0092-8674(00)81199-X
   PubMed Web of Science ®Google Scholar
• Ben-Cherif W, Dridi I, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA. 2012. Chronotolerance study of the antiepileptic drug valproic acid in mice. J Circadian Rhythms. 10:3. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431278/pdf/1740-3391-10-3.pdf10.1186/1740-3391-10-3
   PubMedGoogle Scholar
• Ben-Cherif W, Dridi I, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA. 2013. Circadian variation of valproic acid pharmacokinetics in mice. Eur J Pharm Sci. 49:468–473.10.1016/j.ejps.2013.05.009
   PubMed Web of Science ®Google Scholar
• Berger J. 2008. Advances in chronohaematology. J Appl Biomed. 6:65–72.
   Web of Science ®Google Scholar
• Contalbrigo L, Stelletta C, Falcioni L, Casella S, Piccione G, Soffritti M, Morgante M. 2009. Effects of different electromagnetic fields on circadian rhythms of some haematochemical parameters in rats. Biomed Environ Sci. 22:348–353.10.1016/S0895-3988(09)60067-2
   PubMed Web of Science ®Google Scholar
• Dodge JC, Illig AM, Snyder PJ, Badura LL. 2000. GABA levels within the medial preoptic area: effects of chronic administration of sodium valproic acid. Psychoneuroendocrinology. 25:519–534.10.1016/S0306-4530(00)00007-X
   PubMed Web of Science ®Google Scholar
• Dridi I, Ben-Cherif W, Aouam K, Hassine M, Ben-Attia M, Reinberg A, Boughattas NA. 2013. Circadian variation in haematological toxicity of the immunosuppressive agent “mycophenolate mofetil” in rats. J Appl Biomed. 11:71–78.10.2478/v10136-012-0024-9
   Web of Science ®Google Scholar
• Haque SK, Ariceta G, Batlle D. 2012. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant. 27:4273–4287.10.1093/ndt/gfs493
   PubMed Web of Science ®Google Scholar
• Hawkins E, Brewer E. 1993. Case 4 renal toxicity induced by valproic acid (depakene). Pediatr Pathol. 13:863–868.10.3109/15513819309048273
   PubMed Web of Science ®Google Scholar
• Ibrahim MA. 2012. Evaluation of hepatotoxicity of valproic acid in albino mice, histological and histochemical studies. Life Sci J. 9: 153–159. Available from: http://www.lifesciencesite.com/lsj/life0904/023_10927life0904_153_159.pdf
   Google Scholar
• Jafarian I, Eskandari MR, Mashayekhi V, Ahadpour M, Hosseini MJ. 2013. Toxicity of valproic acid in isolated rat liver mitochondria. Toxicol Mech Methods. 23:617–623.10.3109/15376516.2013.821567
   PubMed Web of Science ®Google Scholar
• Kast A, Nishikawa J, Yabe T, Nanri H, Albert H. 1988. Circadian rhythm of liver parameters (cellular structures, mitotic activity, glycogen and lipids in liver and serum) during three consecutive cycles in phenobarbital-treated rats. Chronobiol Int. 5:363–385.10.3109/07420528809067782
   PubMed Web of Science ®Google Scholar
• Kesterson JW, Granneman GR, Machinist JM. 1984. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology. 4:1143–1152.10.1002/hep.v4:6
   PubMed Web of Science ®Google Scholar
• Khan SK, Shakoor KA, Jan MA, Khattak AM, Shah SH. 2005. Study of histopathological changes in the liver of albino rats, induced by toxic dose of valproic acid. J Med Sci. 3:15–18.
   Google Scholar
• Khedhaier A, Ben-Attia M, Gadacha W, Sani M, Bouzouita K, Chouchane L, Mechkouri M, Reinberg A, Boughattas NA. 2003. Circadian rhythms in toxic effects of the serotonin antagonist ondansetron in mice. Chronobiol Int. 20:1103–1116.10.1081/CBI-120025532
   PubMed Web of Science ®Google Scholar
• Knapp AC, Todesco L, Beier K, Terracciano L, Sägesser H, Reichen J, Krähenbühl S. 2008. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores. J Pharmacol Exp Ther. 324:568–575.
   PubMed Web of Science ®Google Scholar
• Lee MH, Kim M, Lee BH, Kim JH, Kang KS, Kim HL, Yoon BI, Chung H, Kong G, Lee MO. 2008. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver. Toxicol Appl Pharmacol. 226:271–284.10.1016/j.taap.2007.09.014
   PubMed Web of Science ®Google Scholar
• Lemmer B. 1996. The clinical relevance of chronopharmacology in therapeutics. Pharmacol Res. 33:107–115.10.1006/phrs.1996.0016
   PubMed Web of Science ®Google Scholar
• Lewis JH, Zimmerman HJ, Garrett CT, Rosenberg E. 1982. Valproate-induced hepatic steatogenesis in rats. Hepatology. 2:870–873.10.1002/hep.v2.6
   PubMed Web of Science ®Google Scholar
• Liu C, Weaver DR, Strogatz SH, Reppert SM. 1997. Cellular construction of a circadian clock: period determination in the suprachiasmatic nuclei. Cell. 91:855–860.10.1016/S0092-8674(00)80473-0
   PubMed Web of Science ®Google Scholar
• Megarbane B, Deye N, Baud F. 2007. Foie toxique: mécanismes lésionnels et thérapeutiques pharmacologiques spécifiques [Toxic hepatitis: mechanisms of toxicity and specific pharmacological agents]. Réanimation. 16:632–642.10.1016/j.reaurg.2007.08.004
   Google Scholar
• Nalivaeva NN, Belyaev ND, Turner AJ. 2009. Sodium valproate: an old drug with new roles. Trends Pharmacol Sci. 30:509–514.10.1016/j.tips.2009.07.002
   PubMed Web of Science ®Google Scholar
• Nelson W, Tong YL, Lee JK, Halberg F. 1979. Methods for cosinor-rhythmometry. Chronobiologia. 6:305–323.
   PubMedGoogle Scholar
• North C, Feuers RJ, Scheving LE, Pauly JE, Tsai TH, Casciano DA. 1981. Circadian organization of thirteen liver and six brain enzymes of the mouse. Am J Anat. 162:183–199.10.1002/(ISSN)1553-0795
   PubMedGoogle Scholar
• Perucca E. 2002. Pharmacological and therapeutic properties of valproate. CNS Drugs. 16:695–714.10.2165/00023210-200216100-00004
   PubMed Web of Science ®Google Scholar
• Pourahmad J, Eskandari MR, Kaghazi A, Shaki F, Shahraki J, Fard JK. 2012. A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis. Toxicol in Vitro. 26:545–551.10.1016/j.tiv.2012.01.020
   PubMed Web of Science ®Google Scholar
• Raza M, Al-Bekairi AM, Ageel AM, Qureshi S. 1997. Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injury. Pharmacol Res. 35:153–157.10.1006/phrs.1997.0134
   PubMed Web of Science ®Google Scholar
• Raza M, Al-Shabanah OA, Al-Bekairi AM, Qureshi S. 2000. Pathomorphological changes in mouse liver and kidney during prolonged valproate administration. Int J Tissue React. 22:15–21.
   PubMedGoogle Scholar
• Reddy DC, Purushotham KR, Naidu BP. 1980. Circadian rhythmicity in aminotransferases in the Indian field mouse Mus booduga gray. Indian J Exp Biol. 18:1049–1050.
   PubMed Web of Science ®Google Scholar
• Refinetti R. 2006. Variability of diurnality in laboratory rodents. J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 192:701–714.10.1007/s00359-006-0093-x
   PubMed Web of Science ®Google Scholar
• Refinetti R, Cornélissen G, Halberg F. 2007. Procedures for numerical analysis of circadian rhythms. Biol Rhythm Res. 38:275–325.10.1080/09291010600903692
   PubMed Web of Science ®Google Scholar
• Reinberg A. 1992. Concepts in chronopharmacology. Annu Rev Pharmacol Toxicol. 32:51–66.10.1146/annurev.pa.32.040192.000411
   PubMed Web of Science ®Google Scholar
• Reinberg A, Ashkenazi I. 2003. Concepts in human biological rhythms. Dialogues Clin Neurosci. 5:327–342.
   PubMedGoogle Scholar
• Reinberg A, Smolensky M. 1982. Circadian changes of drug disposition in man. J Clin Pharmacokinet. 7:401–420.10.2165/00003088-198207050-00002
   Web of Science ®Google Scholar
• Schmid MM, Freudenmann RW, Keller F, Connemann BJ, Hiemke C, Gahr M, Kratzer W, Fuchs M, Schönfeldt-Lecuona C. 2013. Non-fatal and fatal liver failure associated with valproic acid. Pharmacopsychiatry. 46:63–68.
   PubMed Web of Science ®Google Scholar
• Seidowsky A, Moulonguet-Doleris L, Hanslik T, Yattara H, Ayari H, Rouveix E, Massy ZA, Prinseau J. 2013. Les acidoses tubulaires rénales [Tubular renal acidosis]. La Revue de Médecine Interne. 35:45–55.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, D’alonzo GE. 1993. Medical chronobiology: concepts and applications. Am Rev Respir Dis. 147:S2–S19.10.1164/ajrccm/147.6_Pt_2.S2
   Google Scholar
• Takata M, Burioka N, Ohdo S, Takane H, Terazono H, Miyata M, Sako T. 2002. Daily expression of mrnas for the mammalian clock genes per2 and clock in mouse suprachiasmatic nuclei and liver and human peripheral blood mononuclear cells. Jpn J Pharmacol. 90:263–269.10.1254/jjp.90.263
   PubMedGoogle Scholar
• Tong V, Teng XW, Chang TK, Abbott FS. 2005a. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats. Toxicol Sci. 86:427–435.10.1093/toxsci/kfi184
   PubMed Web of Science ®Google Scholar
• Tong V, Teng WW, Chang TK, Abbott FS. 2005b. Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes. Toxicol Sci. 86:436–443.10.1093/toxsci/kfi185
   PubMed Web of Science ®Google Scholar
• Touitou Y, Portaluppi F, Smolensky MH, Rensing L. 2004. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol Int. 21:161–170.10.1081/CBI-120030045
   PubMed Web of Science ®Google Scholar
• Turek FW, Allada R. 2002. Liver has rhythm. Hepatology. 35:743–745.10.1053/jhep.2002.32873
   PubMed Web of Science ®Google Scholar
• Watanabe M, Miyai A, Danjo S, Nakamura Y, Itoh K. 2013. The threshold of pentylenetetrazole-induced convulsive seizures, but not that of nonconvulsive seizures, is controlled by the nitric oxide levels in murine brains. Exp Neurol. 247:645–652.10.1016/j.expneurol.2013.02.019
   PubMed Web of Science ®Google Scholar
• Wiegand T, Oslon R, Hern E. 2009. Valproate toxicity. Eur J Toxicity. 44:39–42.
   Google Scholar